{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:50:21Z","timestamp":1787007021916,"version":"build-2736575974"},"reference-count":29,"publisher":"Informa UK Limited","issue":"13","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Substance Use & Misuse"],"published-print":{"date-parts":[[2022,11,10]]},"DOI":"10.1080\/10826084.2022.2120366","type":"journal-article","created":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T07:52:16Z","timestamp":1663141936000},"page":"1946-1952","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["Practical Efficacy of Prior Checks on Athletes\u2019 Medication Use for the Prevention of Unintentional Doping"],"prefix":"10.1080","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5372-6038","authenticated-orcid":false,"given":"Takuro","family":"Okada","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan"},{"name":"Department of Pharmacy, Kameda Medical Center, Chiba, Japan"},{"name":"Anti-Doping Committee, Japan Table Tennis Association, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9679-6597","authenticated-orcid":false,"given":"Shiro","family":"Matsuo","sequence":"additional","affiliation":[{"name":"Anti-Doping Committee, Japan Table Tennis Association, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3708-7192","authenticated-orcid":false,"given":"Kazunori","family":"Shimada","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1627-6151","authenticated-orcid":false,"given":"Tohru","family":"Minamino","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,9,14]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjsports-2017-097614"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1080\/10826084.2017.1322105"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjsports-2013-092380"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjsports-2011-090814"},{"key":"e_1_3_4_6_1","unstructured":"Global Drug Reference Online. (2022). Retrieved March 25 2022 from https:\/\/www.globaldro.com\/Home"},{"key":"e_1_3_4_7_1","unstructured":"Japan Anti-Doping Agency. (2016 December 19). Warning regarding higenamine in the 2017 prohibited list. (in Japanese)."},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2012.244"},{"key":"e_1_3_4_9_1","unstructured":"Kyoto Encyclopedia of Genes and Genomes. (2021 April 27). KEGG BRITE Database: Classification of Japanese OTC drugs . Retrieved March 25 2022 from https:\/\/www.genome.jp\/brite\/br08313"},{"key":"e_1_3_4_10_1","unstructured":"Ministry of Internal Affairs and Communications Japan. (1990). Division 87 - Drugs and related commodities . https:\/\/www.soumu.go.jp\/main_content\/000294493.pdf"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1248\/cpb.26.2096"},{"issue":"7","key":"e_1_3_4_12_1","first-page":"549","article-title":"A doping sinner is not always a cheat","volume":"42","author":"Pluim B.","year":"2008","unstructured":"Pluim, B. (2008). A doping sinner is not always a cheat. British Journal of Sports Medicine, 42(7), 549\u2013550.","journal-title":"British Journal of Sports Medicine"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjsports-2014-094538"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/27.6.359"},{"key":"e_1_3_4_15_1","unstructured":"World Anti-Doping Agency. (2009). World Anti-Doping Code 2009. https:\/\/www.wada-ama.org\/sites\/default\/files\/resources\/files\/wada_anti-doping_code_2009_en_0.pdf"},{"key":"e_1_3_4_16_1","unstructured":"World Anti-Doping Agency. (2010). The World Anti-Doping Code. International standard. The 2011 prohibited list . https:\/\/www.wada-ama.org\/sites\/default\/files\/resources\/files\/WADA_Prohibited_List_2011_EN.pdf"},{"key":"e_1_3_4_17_1","unstructured":"World Anti-Doping Agency. (2011). The World Anti-Doping Code. International standard. The 2012 prohibited list . https:\/\/www.wada-ama.org\/sites\/default\/files\/resources\/files\/WADA_Prohibited_List_2012_EN.pdf"},{"key":"e_1_3_4_18_1","unstructured":"World Anti-Doping Agency. (2012). The World Anti-Doping Code. International standard. The 2013 prohibited list . https:\/\/www.wada-ama.org\/sites\/default\/files\/resources\/files\/WADA-Prohibited-List-2013-EN.pdf"},{"key":"e_1_3_4_19_1","unstructured":"World Anti-Doping Agency. (2013). The World Anti-Doping Code. International standard. The 2014 prohibited list . https:\/\/www.wada-ama.org\/sites\/default\/files\/resources\/files\/WADA-prohibited-list-2014-EN.pdf"},{"key":"e_1_3_4_20_1","unstructured":"World Anti-Doping Agency. (2014a). The World Anti-Doping Code. International standard. The 2014 prohibited list Version 2.0 (revised 2014 version). https:\/\/www.wada-ama.org\/sites\/default\/files\/resources\/files\/WADA-Revised-2014-Prohibited-List-EN.PDF"},{"key":"e_1_3_4_21_1","unstructured":"World Anti-Doping Agency. (2014b). The World Anti-Doping Code. International standard. The 2015 prohibited list . https:\/\/www.wada-ama.org\/sites\/default\/files\/resources\/files\/wada-2015-prohibited-list-en.pdf"},{"key":"e_1_3_4_22_1","unstructured":"World Anti-Doping Agency. (2015). The World Anti-Doping Code. International standard. The 2016 prohibited list . https:\/\/www.wada-ama.org\/sites\/default\/files\/resources\/files\/wada-2016-prohibited-list-en.pdf"},{"key":"e_1_3_4_23_1","unstructured":"World Anti-Doping Agency. (2016). The World Anti-Doping Code. International standard. The 2017 prohibited list . https:\/\/www.wada-ama.org\/sites\/default\/files\/resources\/files\/2016-09-29_-_wada_prohibited_list_2017_eng_final.pdf"},{"key":"e_1_3_4_24_1","unstructured":"World Anti-Doping Agency. (2017). The World Anti-Doping Code. International standard. The 2018 prohibited list . https:\/\/www.wada-ama.org\/sites\/default\/files\/prohibited_list_2018_en.pdf"},{"key":"e_1_3_4_25_1","unstructured":"World Anti-Doping Agency. (2018). The World Anti-Doping Code. International standard. The 2019 prohibited list . https:\/\/www.wada-ama.org\/sites\/default\/files\/wada_2019_english_prohibited_list.pdf"},{"key":"e_1_3_4_26_1","unstructured":"World Anti-Doping Agency. (2019). World Anti-Doping Code 2015 with 2019 amendments. https:\/\/www.wada-ama.org\/sites\/default\/files\/resources\/files\/wada_anti-doping_code_2019_english_final_revised_v1_linked.pdf"},{"key":"e_1_3_4_27_1","unstructured":"World Anti-Doping Agency. (2020). 2018 anti-doping rule violations (ADRVs) report . 2020. https:\/\/www.wada-ama.org\/sites\/default\/files\/resources\/files\/2018_adrv_report.pdf"},{"key":"e_1_3_4_28_1","unstructured":"World Anti-Doping Agency. (2021). The World Anti-Doping Code. International standard for therapeutic use exemptions. Therapeutic Use Exemptions . https:\/\/www.wada-ama.org\/sites\/default\/files\/resources\/files\/international_standard_istue_-_2021.pdf"},{"key":"e_1_3_4_29_1","unstructured":"World Anti-Doping Agency. The Prohibited list Q&A. List: Frequently asked questions. Retrieved March 25 2022 from https:\/\/www.wada-ama.org\/en\/prohibited-list#faq-anchor"},{"issue":"1","key":"e_1_3_4_30_1","first-page":"50","article-title":"Analysis of anti-doping consultation activities among domestic Japanese athletes","volume":"18","author":"Yokoi M.","year":"2016","unstructured":"Yokoi, M., Tomiyama, N., & Tashiro, T. (2016). Analysis of anti-doping consultation activities among domestic Japanese athletes. Japanese Journal of Drug Informatics, 18(1), 50\u201357.","journal-title":"Japanese Journal of Drug Informatics,"}],"container-title":["Substance Use & Misuse"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/10826084.2022.2120366","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T14:20:19Z","timestamp":1703082019000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/10826084.2022.2120366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,14]]},"references-count":29,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2022,11,10]]}},"alternative-id":["10.1080\/10826084.2022.2120366"],"URL":"https:\/\/doi.org\/10.1080\/10826084.2022.2120366","relation":{},"ISSN":["1082-6084","1532-2491"],"issn-type":[{"value":"1082-6084","type":"print"},{"value":"1532-2491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,14]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=isum20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=isum20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-09-14","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}